COLECTOMY OUTCOMES IN APPALACHIAN AND NON-APPALACHIAN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A SINGLE CENTER STUDY

Abstract BACKGROUND Inflammatory bowel disease (IBD) requires complex management, and colectomy is an important intervention when medical therapy fails or complications arise. Postoperative outcomes vary by disease type, perioperative management, and patient characteristics. Appalachian populations are known to experience higher comorbidity burden, socioeconomic challenges, and healthcare disparities, yet surgical outcomes in this group remain poorly studied. METHODS We conducted a retrospective analysis of patients with IBD who had undergone colectomy using the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) data from January 2016 through August 2023. Patients were stratified by county of residence, classified using the Appalachian Regional Commission (ARC) economic distress index. The ARC designates counties into five categories ranging from 「attainment」 to 「distressed」 based on poverty, unemployment, and per capita income. Patients with redo colectomy procedures (n = 5) and those residing outside Appalachian states (n = 7) were excluded. Primary outcomes were hospital length of stay, 30-day mortality, and 30-day readmission. Secondary outcomes included operative approach and perioperative factors. RESULTS A total of 293 patients with IBD who had undergone colectomy were identified. After exclusions, 281 patients were included: 186 (66.2%) from Appalachian counties and 95 (33.8%) from non-Appalachian counties. The mean age was 41.7 years, and 49.1% were male. Most patients were White (93.2%), with 5.7% Black or African American. Economic classifications included 37.7% from distressed counties, 20.6% at risk, 40.6% transitional, and 1.1% competitive. Most procedures were performed for Crohn’s Disease (80.4%), were laparoscopic (80.0%) and non-emergent (92.2%). Operative approaches were similar between groups. Appalachian patients demonstrated higher 30-day mortality (3.3% vs 1.1%, p = 0.17) and higher 30-day in-hospitalization (2.7% vs 0%, p = 0.43). Contrary to our hypothesis, 30-day readmission was lower among Appalachian patients compared with non-Appalachian patients (5.4% vs 10.5%, p = 0.146). CONCLUSION Although not statistically significant, Appalachian patients who had undergone colectomy demonstrated higher short-term mortality and hospitalization, while readmission rates were lower. These trends suggest potential differences in outcomes influenced by geography, socioeconomic distress, and healthcare access. Further investigation using multicenter data is warranted to better define surgical risks and develop strategies to reduce disparities in Appalachian populations with IBD.

Authors

Publication Details

Journal
Inflammatory Bowel Diseases
Published
2026-01-22
DOI
https://doi.org/10.1093/ibd/izag006.079
Primary Topic
Inflammatory Bowel Disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

COLECTOMY OUTCOMES IN APPALACHIAN AND NON-APPALACHIAN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A SINGLE CENTER STUDY

Henry C. Shay, Avinash Bhakta, Brittany E. Levy, Daniel Davenport
Inflammatory Bowel Diseases
Inflammatory Bowel Disease
article

COLECTOMY OUTCOMES IN APPALACHIAN AND NON-APPALACHIAN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A SINGLE CENTER STUDY

Henry C. Shay, Avinash Bhakta, Brittany E. Levy, Daniel Davenport
article en

Abstract

Abstract BACKGROUND Inflammatory bowel disease (IBD) requires complex management, and colectomy is an important intervention when medical therapy fails or complications arise. Postoperative outcomes vary by disease type, perioperative management, and patient characteristics. Appalachian populations are known to experience higher comorbidity burden, socioeconomic challenges, and healthcare disparities, yet surgical outcomes in this group remain poorly studied. METHODS We conducted a retrospective analysis of patients with IBD who had undergone colectomy using the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) data from January 2016 through August 2023. Patients were stratified by county of residence, classified using the Appalachian Regional Commission (ARC) economic distress index. The ARC designates counties into five categories ranging from 「attainment」 to 「distressed」 based on poverty, unemployment, and per capita income. Patients with redo colectomy procedures (n = 5) and those residing outside Appalachian states (n = 7) were excluded. Primary outcomes were hospital length of stay, 30-day mortality, and 30-day readmission. Secondary outcomes included operative approach and perioperative factors. RESULTS A total of 293 patients with IBD who had undergone colectomy were identified. After exclusions, 281 patients were included: 186 (66.2%) from Appalachian counties and 95 (33.8%) from non-Appalachian counties. The mean age was 41.7 years, and 49.1% were male. Most patients were White (93.2%), with 5.7% Black or African American. Economic classifications included 37.7% from distressed counties, 20.6% at risk, 40.6% transitional, and 1.1% competitive. Most procedures were performed for Crohn’s Disease (80.4%), were laparoscopic (80.0%) and non-emergent (92.2%). Operative approaches were similar between groups. Appalachian patients demonstrated higher 30-day mortality (3.3% vs 1.1%, p = 0.17) and higher 30-day in-hospitalization (2.7% vs 0%, p = 0.43). Contrary to our hypothesis, 30-day readmission was lower among Appalachian patients compared with non-Appalachian patients (5.4% vs 10.5%, p = 0.146). CONCLUSION Although not statistically significant, Appalachian patients who had undergone colectomy demonstrated higher short-term mortality and hospitalization, while readmission rates were lower. These trends suggest potential differences in outcomes influenced by geography, socioeconomic distress, and healthcare access. Further investigation using multicenter data is warranted to better define surgical risks and develop strategies to reduce disparities in Appalachian populations with IBD.

Inflammatory Bowel DiseasesVol. 32(Supplement_1)
No poverty
Openalex Percentile: Top 75%
Inflammatory Bowel Disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.